FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Aurobindo Recalls Healthy Living Migraine Relief

FDA says Aurobindo has recalled one lot of its OTC Healthy Living migraine medication that was distributed through Amazon without the FDA-approved lab...

Animal Drugs

VICH Residual Solvents Guidance

FDA publishes a Veterinary International Conference on Harmonization revised guidance on residual solvents used in animal drugs.

latest-news-card-1
Federal Register

Guide on e-Health Records to Support Submissions

Federal Register notice: FDA makes available a final guidance entitled Real-World Data: Assessing Electronic Health Records and Medical Claims Data To...

latest-news-card-1
Medical Devices

Medtronic Recalls NIM Vital Nerve Monitor

Medtronics Xomed unit recalls (Class 1) its NIM Vital Nerve Monitoring system due to the potential for false negative responses.

latest-news-card-1
Biologics

Covid-19 Convalescent Plasma Guidance

FDA publishes an immediately effective guidance with its recommendations for investigational and licensed Covid-19 convalescent plasma.

latest-news-card-1
Biologics

Recommend Transition to HTS Technology: MIT Letter

Two stakeholders call for changes to an FDA draft guidance on safety testing of human allogeneic cells expanded for use in cell-based medical products...

latest-news-card-1
FDA General

House FDA Budget Bill Floor Vote Scrapped

House Republican leaders postpone a floor vote this week on FDAs fiscal year 2025 budget.

latest-news-card-1
Human Drugs

Mirums Livmarli Gets Expanded Label

FDA approves a Mirum Pharmaceuticals label expansion for Livmarli (maralixibat) oral solution for treating cholestatic pruritus in patients with progr...

latest-news-card-1
Human Drugs

Abbott Recalls FreeStyle Libre 3 Sensors

Abbott begins a medical device correction for some of its FreeStyle Libre 3 sensors due to potential incorrect high glucose readings.

latest-news-card-1
Human Drugs

FDA Fast Track for AC Immune Alzheimers Drug

FDA grants fast-track designation to AC Immunes investigational candidate being developed with Janssen for Alzheimers disease.